Danger Bio

Danger Biois developing a portfolio of novel therapeutics targeting key imbalances in danger detection, clearance, and innate-immune activation biology — to interrupt autoimmunity and chronic-inflammatory cycles, and to "reboot" tumor microenvironments to unlock better immunotherapy response rates.